NCT01878487

Brief Summary

To use IVUS to assess (1) culprit plaque morphology and thrombus burden in patients with ST-elevation myocardial infarction; (2) the efficacy of thrombus removal with an aspiration catheter in 40 patients during primary PCI.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2012

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2012

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

May 1, 2013

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2013

Completed
2 months until next milestone

First Posted

Study publicly available on registry

June 17, 2013

Completed
Last Updated

October 12, 2015

Status Verified

October 1, 2015

Enrollment Period

1.3 years

First QC Date

May 1, 2013

Last Update Submit

October 7, 2015

Conditions

Keywords

Acute MIPrimary percutaneous coronary interventionthrombus aspiration, IVUS

Outcome Measures

Primary Outcomes (1)

  • Coronary artery lumen expansion after thrombus aspiration in primary percutaneous intervention.

    Degree of thrombus extraction can be visualised immediately by intravascular ultrasound (IVUS) but detailed analysis will be carried out off-line and by histopathology of aspirated material within 4 months.

    Day 1

Study Arms (1)

Only one arm

OTHER

All patients will receive the same treatment, i.e. there is no randomization. There is therefore only one arm, all patients will by treated as per standard practice with thrombus aspiration and stenting as required, the lumen size of the vessel will be assessed with intravascular ultrasound at baseline, after thrombus aspiration and after stenting.

Device: Thrombus aspiration (Intravascular Ultrasound catheter (Boston))

Interventions

There is a single arm in the study where all patients are undergoing primary percutaneous coronary intervention for an acute myocardial infarction. All patients will have an Intravascular Ultrasound three times: 1. At baseline 2. After thrombus aspiration with a thrombus extraction catheter 3. After stent deployment We are however assessing the physiological response of patients having an acute myocardial infarction and this is not a test of the devices as such.

Also known as: Export thrombus aspiration cathether, Intravascular Ultrasound catheter (Boston)
Only one arm

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients 18-75 years old with myocardial infarction with ST-segment elevation
  • symptoms of myocardial ischemia lasting more than 30 minutes
  • onset of symptoms within 12 hours of hospital presentation
  • ST-segment elevation of more than 0.1 mV in two or more leads on the ECG

You may not qualify if:

  • inability to obtain informed consent
  • use of fibrinolytic drug within 12 hours of presentation
  • comorbidity with anticipated life expectancy of \< 6 months
  • cardiogenic shock on presentation
  • major bleeding diathesis
  • history of aspirin and clopidogrel intolerance
  • critical left main stem lesions
  • severe calcfic disease precluding safe passage of the imaging catheter
  • culprit lesion within saphenous vein grafts

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Cardiology, Freeman Hospital

Newcastle, United Kingdom

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 1, 2013

First Posted

June 17, 2013

Study Start

January 1, 2012

Primary Completion

May 1, 2013

Study Completion

May 1, 2013

Last Updated

October 12, 2015

Record last verified: 2015-10

Locations